International Patent: ANTITUMOR OR TUMOR METASTASIS-INHIBITING COMPOSITION CONTAINING LACTOBACILLUS REUTERI ATG-F4 STRAIN AS ACTIVE INGREDIENT

GENEVA, July 31 -- ATOGEN CO., LTD. filed a patent application (KR2026/095022) for “ANTITUMOR OR TUMOR METASTASIS-INHIBITING COMPOSITION CONTAINING LACTOBACILLUS REUTERI ATG-F4 STRAIN AS ACTIVE INGREDIENT”. With publication no. WO/2026/160949, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 35/747

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....